Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Analyst picks & changes

Chiron Corp.

(CHIR)

North American Vaccine Inc.

(NVX)

Business: Infectious diseases

Oppenheimer's Geller said the acellular pertussis vaccines developed by CHIR, NVX,

SmithKline Beecham

and Connaught are equally safe and

Read the full 318 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE